Variational AI will participate in ALL IN Talks West, an event bringing together researchers, industry leaders, builders, and decision-makers focused on the practical deployment of artificial intelligence systems in real-world environments. “From World-Class Research to Market Impact: Closing the Adoption Gap.” Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, will speak on April

Learn More about Variational AI to speak at ALL IN Talks West

Variational AI will participate in the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), one of North America’s leading gatherings for healthcare investors and emerging life sciences companies. Meet with Variational AI Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, will attend the conference to meet with investors and discuss the company’s approach

Learn More about Variational AI to Participate in the Bloom Burton Healthcare Investor Conference

Variational AI will participate in MaRS Impact Health, a flagship health innovation event hosted by MaRS Discovery District that brings together entrepreneurs, investors, scientists, clinicians, and policymakers working to advance the future of healthcare. Meet with Variational AI If you are attending MaRS Impact Health and would like to connect with Variational AI to learn

Learn More about Variational AI to Participate in the MaRS Impact Health Summit

Variational AI will participate in the upcoming Boston Pharmaceutical & Bioscience Society (PBSS) event, “Artificial Intelligence and Machine Learning: Shaping the Future of Therapeutic Drug Discovery, Development, and Manufacturing,” taking place April 28, 2026, in Cambridge, MA. This full-day symposium brings together leaders from biotechnology, academia, and pharmaceutical companies to discuss how artificial intelligence and

Learn More about Variational AI to Present at PBSS Event on AI and ML in Drug Discovery

Variational AI is excited to be joining Web Summit Vancouver 2026, one of the world’s premier technology conferences, bringing together over 20,000 attendees, investors, and innovators from across the globe — right here in Vancouver. Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, will participate as a panelist at the event, and Valentin

Learn More about Variational AI at WebSummit Vancouver 2026

Variational AI will be attending BIO International Convention 2026 in San Diego. We’ll be onsite for partnering meetings to connect with pharma and biotech teams interested in accelerating small-molecule programs with generative AI—especially where speed, novelty, and multi-parameter optimization are key. Our delegation will include: Handol Kim, CEO Pete Guzzo, EVP & Head of Drug

Learn More about Variational AI at BIO International Convention 2026

Variational AI will be at the CCG North American UGM & Conference in Montreal (June 23–26, 2026). Join Alex Perryman’s scientific presentation on June 25 on how MOE supported multiple drug discovery programs.

Learn More about Variational AI at CCG’s North American UGM & Conference 2026

Variational AI will participate in Discovery on Target (DOT) 2026, a leading conference dedicated to the latest advances in drug targets and enabling technologies for therapeutic discovery. Held annually in Boston, Discovery on Target brings together scientists from pharma, biotech, and academia to explore emerging approaches for identifying and validating novel drug targets, as well

Learn More about Variational AI at Discovery on Target 2026

Variational AI will participate in BIO-Europe 2026, one of the world’s leading partnering conferences for the biotechnology and pharmaceutical industries. The event brings together biotech companies, pharmaceutical firms, investors, and technology innovators from across the global life sciences ecosystem to explore partnerships, licensing opportunities, and new approaches to advancing therapeutic development. Meet the Variational AI

Learn More about Variational AI at BIO-Europe 2026